stockrowAquestive Therapeutics, Inc. (AQST) vs Evolus, Inc. (EOLS)
- Aquestive Therapeutics, Inc. AQST 3.62 −1.09%
- Evolus, Inc. EOLS 6.84 +0.59%
Aquestive Therapeutics, Inc. and Evolus, Inc. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. and Evolus, Inc. are of similar size ($460.0M and $448.8M). Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 12.5%. Evolus, Inc. has the higher net margin (−9.56% vs −162.3%) and the lower return on invested capital (−12.6% vs 0.00%). Across the 17 metrics below, Evolus, Inc. leads on 14 and Aquestive Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | AQST | EOLS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.34% | 66.38% | 53.51% |
| Operating margin | (114.12%) | (4.79%) | 0.00% |
| Net margin | (162.33%) | (9.56%) | (2.45%) |
| Free cash flow margin | (83.33%) | (2.71%) | 0.00% |
| Return on equity | 211.59% | 93.47% | (0.80%) |
| Return on assets | (56.05%) | (12.38%) | (1.67%) |
| Return on invested capital | 0.00% | (12.60%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack